Halozyme Therapeutics
HALO
#2417
Rank
$7.36 B
Marketcap
$62.65
Share price
1.26%
Change (1 day)
27.70%
Change (1 year)

Market capitalization of Halozyme Therapeutics (HALO)

Market cap: $7.36 Billion USD

As of December 2025 Halozyme Therapeutics has a market cap of $7.36 Billion USD. This makes Halozyme Therapeutics the world's 2417th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Halozyme Therapeutics from 2004 to 2025

End of year Market Cap

Year Marketcap Change
2025$7.36 B20.32%
2024$6.12 B25.42%
2023$4.88 B-36.54%
2022$7.69 B35.9%
2021$5.66 B-1.95%
2020$5.77 B138.2%
2019$2.42 B14.48%
2018$2.11 B-26.59%
2017$2.88 B125.44%
2016$1.27 B-42.39%
2015$2.22 B83.06%
2014$1.21 B-29.34%
2013$1.71 B127.01%
2012$0.75 B-23.31%
2011$0.98 B23.79%
2010$0.79 B48.02%
2009$0.53 B18%
2008$0.45 B-17.66%
2007$0.55 B0.1%
2006$0.55 B404.64%
2005$0.10 B1.3%
2004$0.10 B

End of Day market cap according to different sources

On Dec 10th, 2025 the market cap of Halozyme Therapeutics was reported to be:

$7.36 Billion USD
by Nasdaq info icon info icon
$7.36 Billion USD
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
MannKind Corp
MNKD
$1.79 B-75.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$890.75 B 11,990.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
$9.38 B 27.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$146.57 B 1,889.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
$117.79 B 1,498.91%๐Ÿ‡ซ๐Ÿ‡ท France
Johnson & Johnson
JNJ
$497.61 B 6,654.25%๐Ÿ‡บ๐Ÿ‡ธ USA